Global Alzheimer's Disease Market Will Grow at a CAGR 15.5% and Reach USD 6.88 Billion by 2023, from USD 2.9 Billion in 2017

New Global Alzheimer's Disease Market Report Covers market forecast and top Companies like Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma and others.

Logo

Lewes, DE -- (SBWire) -- 08/01/2018 --Alzheimer's Disease Market will register a 15.5% CAGR in terms of revenue, reach US$ 6880 million by 2023, from US$ 2900 million in 2017.

Alzheimer's disease is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss).

Over the next five years,study projects that Alzheimer's Disease will register a 15.5% CAGR in terms of revenue, reach US$ 6880 million by 2023, from US$ 2900 million in 2017.

This report studies the global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck

Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 (forecast), like
North America (United States, Canada and Mexico)
Asia-Pacific (China, Japan, Southeast Asia, India and Korea)
Europe (Germany, UK, France, Italy and Russia etc.)
South America (Brazil, Chile, Peru and Argentina)
Middle East and Africa (Egypt, South Africa, Saudi Arabia)

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
Donepezil
Memantine
Rivastigmine

Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into
Early to Moderate Stages
Moderate to Severe Stages

Spanning over 124 pages "Forecast of Global Alzheimer's Disease Market 2023" report covers Alzheimer's Disease Market Overview, Global Alzheimer's Disease Sales, Revenue (Value) and Market Share by Players, Global Alzheimer's Disease Sales, Revenue (Value) by Regions, Type and Application (2013-2018), North America Top 5 Players Alzheimer's Disease Sales, Revenue and Price, Europe Top 5 Players Alzheimer's Disease Sales, Revenue and Price, Asia-Pacific Top 5 Players Alzheimer's Disease Sales, Revenue and Price, South America Top 5 Players Alzheimer's Disease Sales, Revenue and Price, Middle East & Africa Top 5 Players Alzheimer's Disease Sales, Revenue and Price, Global Alzheimer's Disease Players Profiles/Analysis, Global Alzheimer's Disease Market Forecast (2018-2023), Alzheimer's Disease Manufacturing Cost Analysis, Industrial Chain, Sourcing Strategy and Downstream Buyers, Marketing Strategy Analysis, Distributors/Traders, Market Effect Factors Analysis, Research Findings and Conclusion, Appendix.

Please visit this link for more details: https://www.marketresearchreports.com/mrrpb2/forecast-global-alzheimers-disease-market-2023

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

For related reports please visit: https://www.marketresearchreports.com/search/site/Alzheimer%2527s%2520Disease

Read our Interactive Market Research Blog

About MarketResearchReprots.com
MarketResearchReprots.com is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Contact us for your market research requirements:https://www.marketresearchreports.com/contact

Media Relations Contact

Sudeep Chakravarty
Director - Operations
MarketResearchReprots.com
1-302-703-9904
https://www.marketresearchreports.com/mrrpb2/forecast-global-alzheimers-disease-market-2023

View this press release online at: http://rwire.com/1021856